Abbvie Inc (NYSE: ABBV): Hunting Genuine Value In Market Debris
The Vanguard Group, Inc. recently announced the acquisition of new stake in Abbvie Inc (NYSE:ABBV). The institutional investor has increased its shareholding in the Healthcare company by 0.89% to 153.0 million shares with purchase of 1.35 million shares. This fresh investment now brings its stake to 8.67% valued currently at $21.6 billion. In addition, JPMorgan […]
Are Analysts Expecting A Better 2020 For Abbvie Inc (ABBV)?
BlackRock Fund Advisors has recently announced that it has increased stake in Abbvie Inc (NYSE:ABBV) by 0.79%. After grabbing 91.67 million shares, the institutional investor is now in possession of 0.72 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.19% having worth around $13.66 billion. Moreover, SSgA […]
